Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Pharma

Antidepressant fluvoxamine could treat COVID-19

Researchers from Washington University School of Medicine are now conducting a clinical trial of antidepressant drug fluvoxamine, as a potential treatment for the ‘cytokine storm’ associated with COVID-19. If found effective, this selective serotonin reuptake inhibitor (SSRI) could be rapidly made available to patients as it is already globally marketed and has a known safety record, […]
Read more

Moderna’s and Inovio’s Phase III COVID-19 trials face operational obstacles

Following the announcement of Moderna’s interim data for its Phase I COVID-19 vaccine trial; Reynald Castañeda, Pharma Writer for the Investigative News team at GlobalData, offers his view: “Moderna’s registrational trial will face substantial operational challenges, despite having a low success bar for efficacy. Moderna, which stocks shot up almost 30% premarket in reaction to today’s […]
Read more

COVID-19 pandemic and opioid use disorder epidemic could impact and worsen each other

COVID-19 pandemic and opioid use disorder (OUD) are intersecting and worsening each other, demanding a rapid response to correct the underlying factors, says GlobalData, a leading data and analytics company. Arunkumar NV, Epidemiologist at GlobalData, comments “Impaired psychosocial wellbeing, due to unstable socio-economic situations and disrupted opioid addiction treatment schedules, will cause an increasing wave […]
Read more

COVID-19’s effect will boost infectious disease drug approvals and present opportunities to CMOs

In response to the global pandemic, biopharma companies have put a renewed emphasis on finding treatments for infectious diseases, including COVID-19 and other infectious diseases overall. In early May, there were 312 novel pipeline drugs for COVID-19, of which 11 were in Phase III trials, according to GlobalData’s Drugs database. Adam Bradbury, Associate Analyst at GlobalData […]
Read more

COVID-19 clinical trials exhibit encouraging results, says GlobalData

With the number of COVID-19 cases and deaths increasing with each passing day, the need for a therapeutic or a vaccine for the pandemic intensifies. Currently, 21 ongoing COVID-19 clinical trials have reported interim results, out of which 16 showed positive early results, says GlobalData, a leading data and analytics company. Scotty Chung-Siu, Senior Analyst […]
Read more

More than half of all age-related macular degeneration cases go undiagnosed

In the nine major pharmaceutical markets (9MM*), less than half of age-related macular degeneration (AMD) cases were diagnosed in 2019 in adults aged 50 years and older, according to GlobalData, a leading data and analytics company. The company’s latest report, ‘Age-Related Macular Degeneration: Epidemiology Forecast to 2028’, revealed that Japan and China experienced the most […]
Read more

COVID-19 continues to disrupt clinical trials, with 69.9% of disruptions due to the suspension of enrolment

Clinical trials across the globe continue to be disrupted due to COVID-19. According to GlobalData, a leading data and analytics company, among global clinical trials that have been disrupted since April 2020, 69.9% are due to the suspension of enrolment, 17.3% due to slow enrolment and 12.8% due to delayed initiation. Furthermore, within the 17.3% of trials affected by slow enrolment, […]
Read more

Healthcare systems will remain under increased pressure of cyberattacks even after COVID-19 outbreak ends

With the scale and complexity of cybercrime increasing, and the fact that hospitals are moving toward digitalization and remote patient care, the number of cyberattacks on healthcare systems will continue to increase, says GlobalData, a leading data and analytics company. Urte Jakimaviciute, MSc, Senior Director of Market Research at GlobalData, comments: “Since the emergence of […]
Read more

Lack of patient selection holds back new combinations in melanoma

Targeted therapies have delivered on their promise to make oncology more personalized. However, the addition of immunotherapy agents without first testing for patients who are most likely to benefit may limit the success of triplet combinations in melanoma, says GlobalData, a leading data and analytics company. The addition of Tecentriq (atezolizumab) to a doublet therapy […]
Read more

FDA new drug approvals down 16% in 2019

In 2019 the US Food and Drug Administration (FDA) accepted 119 New Drug Approvals (NDAs) and Biologics License Applications (BLAs) including New Molecular Entities (NMEs) and new formulations of older drugs. This figure represents a 3% increase over the 2014–2018 period average of 115 approvals, but is a 16% decrease on 2018’s 137 approvals, according […]
Read more

ICMR banks on Bharat Biotech expertise to develop COVID-19 vaccine in India, says GlobalData

Following the news that Indian Council of Medical Research (ICMR) and India-based Bharat Biotech have partnered to develop an indigenous COVID-19 vaccine; Anupama, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view: “ICMR selected Bharat Biotech due to its expertise in indigenous vaccine development. COVID-19 virus isolate obtained from ICMR’s National […]
Read more

Fujifilm and Ansun’s efforts to repurpose their influenza therapies to treat COVID-19 draw efficacy skepticism

With Fujifilm Toyama Chemical’s Avigan (favipiravir) already approved in Japan for influenza, that country had announced plans to stockpile two million courses of the oral drug for COVID-19, but reporting by Reynald Castañeda, Pharma Writer for the Investigative News team at GlobalData, a leading data and analytics company, notes that there are reservations about the drug’s potential in treating […]
Read more

COVID-19 pandemic could cause increase in prevalence of PTSD

A significant increase in the total prevalence of PTSD is expected globally amid the COVID-19 pandemic – with the risk for women being twice as high as men, says GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Post-Traumatic Stress Disorder: Epidemiology Forecast to 2028’, notes that the 12-month total prevalence of PTSD in the […]
Read more

BCG vaccines being tested for protection against COVID-19

As the COVID-19 pandemic continues to spread, researchers are examining reasons why various countries were impacted differently. It has been suggested that the severity of COVID-19 is higher in countries that do not have a history of Bacillus Calmette–Guerin (BCG) vaccination programs. Clinical trials are underway to investigate the possibility that they confer some immunity […]
Read more
1 … 92 93 94 95 96 … 108